tradingkey.logo

Nasus Pharma Ltd

NSRX
5.440USD
-0.550-9.18%
종가 02/06, 16:00ET시세는 15분 지연됩니다
49.28M시가총액
손실P/E TTM

Nasus Pharma Ltd

5.440
-0.550-9.18%

자세한 내용은 Nasus Pharma Ltd 회사

Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.

Nasus Pharma Ltd 정보

종목 코드 NSRX
회사 이름Nasus Pharma Ltd
상장일Aug 13, 2025
CEOTeleman (Dan)
직원 수- -
유형Ordinary Share
회계 연도 종료Aug 13
주소Yigal Alon 65
도시TEL AVIV-YAFO
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가Israel
우편 번호- -
전화97237326616
웹사이트https://www.nasuspharma.com
종목 코드 NSRX
상장일Aug 13, 2025
CEOTeleman (Dan)

Nasus Pharma Ltd의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.90M
+55292.00%
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
+42854.00%
Mr. Dan Teleman
Mr. Dan Teleman
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Tair Lapidot, Ph.D.
Dr. Tair Lapidot, Ph.D.
Vice President of Research and Development and Clinical Development
Vice President of Research and Development and Clinical Development
--
--
Galia Temtsin Kryaz
Galia Temtsin Kryaz
Director of CMC and Product Development
Director of CMC and Product Development
--
--
Mr. Oren Elmaliach
Mr. Oren Elmaliach
Director of Finance
Director of Finance
--
--
Mr. Ronnie Hershman
Mr. Ronnie Hershman
Independent Director
Independent Director
--
--
Mr. David Silberman, CPA
Mr. David Silberman, CPA
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Sharon Shacham, Ph.D.
Dr. Sharon Shacham, Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Isaac Israel
Isaac Israel
Independent Director Nominee
Independent Director Nominee
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.90M
+55292.00%
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
+42854.00%
Mr. Dan Teleman
Mr. Dan Teleman
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Tair Lapidot, Ph.D.
Dr. Tair Lapidot, Ph.D.
Vice President of Research and Development and Clinical Development
Vice President of Research and Development and Clinical Development
--
--
Galia Temtsin Kryaz
Galia Temtsin Kryaz
Director of CMC and Product Development
Director of CMC and Product Development
--
--
Mr. Oren Elmaliach
Mr. Oren Elmaliach
Director of Finance
Director of Finance
--
--

수익 분석

기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
Gilboa (Udi)
21.09%
Megiddo (Dalia)
20.96%
Hershman Holdings L.L.C.
9.89%
Capital Point Ltd
6.38%
Phoenix Solutions Ltd
4.76%
기타
36.92%
주주
주주
비율
Gilboa (Udi)
21.09%
Megiddo (Dalia)
20.96%
Hershman Holdings L.L.C.
9.89%
Capital Point Ltd
6.38%
Phoenix Solutions Ltd
4.76%
기타
36.92%
주주 유형
주주
비율
Individual Investor
43.95%
Corporation
21.03%
Investment Advisor
0.03%
기타
34.99%

기관 주식 보유

마지막 업데이트: Wed, Jan 21
마지막 업데이트: Wed, Jan 21
보고 기간
기관 수
보유 주식
비율
변동
2026Q4
2
3.24K
0.00%
--
2025Q4
2
2.38K
0.03%
+1.14K
2025Q3
7
5.35M
59.33%
+5.35M

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Gilboa (Udi)
1.90M
21.09%
+55.29K
+3.00%
Sep 30, 2025
Megiddo (Dalia)
1.89M
20.96%
+42.85K
+2.32%
Sep 30, 2025
Hershman Holdings L.L.C.
891.19K
9.89%
+414.18K
+86.83%
Sep 30, 2025
Capital Point Ltd
575.13K
6.38%
+575.13K
--
Aug 14, 2025
Phoenix Solutions Ltd
429.31K
4.76%
--
--
Sep 30, 2025
Krayz (Galia Temtsin)
171.72K
1.91%
+171.72K
--
Aug 12, 2025
Morgan Stanley Smith Barney LLC
2.00K
0.02%
+2.00K
--
Sep 30, 2025
UBS Financial Services, Inc.
1.24K
0.01%
+1.24K
--
Sep 30, 2025
Lapidot (Tair Ph.D.)
10.00
0%
+10.00
--
Aug 12, 2025

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI